Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Pam Dhadda

Pam Dhadda

Regulatory Affairs Consultant, Cell & Gene Therapy, ERA Consulting

Pam is a consultant in the ERA Cell and Gene Therapy team.  She has a strong background in the development of Advanced Therapeutic Medicinal Products, encompassing both academic research and manufacturing development activities.  She has supported IND/IMPD activities and Scientific Advice Consultations in the US, Europe and Japan, for early phase ATMP development. Pam’s manufacturing development background was founded at the Cell and Gene Therapy Catapult where she was involved in numerous projects developing bioprocessing strategies to support cell and gene therapy manufacture.  Pam has a PhD in Regenerative Medicine from King’s College London in which she explored the use of Mesenchymal Stromal Cells for improving the outcome of Islet Transplantation as part of the Diabetes Research Group.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd